chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I got a large hot red rash at the site of injection, it spread to the rest of my body. It was exactly 7 days after getting the shot. I went to the doctor and was given NAC, Allergy medication, Prednisone, famotidine, and Triamcinolone to treat.
My blood sugar was slightly elevated (170mg/dl) 12-24h post injection and severely elevated (200-270 mg/dl) 24-32h after injection; More significantly my body was insulin resistant during that time; This is a spontaneous report from a contactable consumer (patient). A 36-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: Em9810, expiration date not reported), via an unspecified route of administration in right arm on 08Feb2021 at 09:30 (age at vaccination was 36 years) as a single dose for covid-19 immunization. The facility where most recent COVID-19 vaccine was administered was other. Medical history included type 1 diabetes, asthma and allergy to sulfas. Concomitant medications included aspart (FIASP INSULIN), minerals nos, vitamins nos (CENTRUM), vitamin d nos and cetirizine hydrochloride (ZYRTEC); the patient received all these within 2 weeks of vaccination, the patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) administered in right arm on 18Jan2021 at 10:30 (Batch/Lot Number: EI3302) as a single dose for covid-19 immunization. The patient was type 1 diabetic. On 08Feb2021 at 20:00 patients blood sugar was slightly elevated (170mg/dl) 12-24h post injection and severely elevated (200-270mg/dl) 24-32h after injection. More significantly his body was insulin resistant during that time. At time of writing, it was 35h past injection and blood sugar has normalized and insulin again started behaving normally. The event was reported as non-serious with no seriousness criteria (Results in death / Life threatening/ Caused/prolonged hospitalization/ Disabling/Incapacitating/ Congenital anomaly/birth defect). The outcome of the events was recovered/resolved in 2021.
Vaccine was given after expiration date.  Expiration date was 9/30/22
1 week after my first dose my fingers started to peel. Since then I has spread all the way to my wrist. Multiple layers of skin are peeling off; sometimes so much it is causing bleeding. This past Monday 9/6 my toes started to peel and now it has spread to the bottom and tops of both feet.
I contracted COVID-19 on 03/27/2022 with symptoms of sore throat, fatigue, fever of over 101 at highest point with it lasting for 10 days, cough, loss of voice for 3 days, chest tightness/pain, and shortness of breathe. I had a telemedicine visit on 04/01/2022 when I began having trouble breathing, there was concern that I was developing COVID-19 Pneumonia so I was prescribed an albuterol inhaler, prednisone, and Zithromax. I was ill for 10 day, and the cough has lingered on and off since being ill.
Sore throat, back ache, stomach ache, headache, nausea, vomiting, fatigue. Treatment: Toradol, IV fluids, labwork.
Symptoms ? Patient reports around 11:00 am began feeling nauseated and emesis x 3 (last emesis at ~12:00 pm)? and + dizziness.  RN asked Patient to take her temp while on call, temp 98.2.  Patient denies recent exposure to COVID-19 without proper PPE and denies travel.  Patient denies other symptoms at this time.   Last day of work and shift ? currently at work Home remedies? -  none Any improvement? ? none Recommendation? Patient encouraged to continue to monitor her symptoms and to contact the Vaccine support line with additional questions and concerns.  Patient reports she is currently at work and educated of Illness in the Workplace Policy and to notify her manager if she needs to leave work and go home.   Patient verbalized back understanding and denied further questions at this time.
Patient began experiencing redness, warmth, and swelling at the injection site, which began to travel down the arm. Reaction did not occur until 6 days after the injection.
Dose 1 given 2/10/2021 Moderna Lot # 024M20A  Patient tested positive for Covid on 5/22/2022, died on 5/23/2022 at hospital.
Following varicella vaccine # 1 c/o pimple-like eruptions generalized over body x 1 week.
Information has been received from a registered nurse concerning a child patient who on approximately 30-AUG-2010 "week of 30-AUG-2010", was vaccinated with a dose of VARIVAX (Merck) (Lot#: 667293/0640Z). Lab diagnostics studies were not performed. Subsequently, on an unspecified date, the patient's area was very red, swollen and painful at injection site. There was a picture of the reaction if needed. Office staff member felt it was more of a reaction "than she had ever seen". At the time of the report, the patient's outcome was unknown. The patient sought unspecified medical attention. This is one of several reports received from the same source. No further information is available.
Sore arm, irregular menstrual cycle, it was longer and heavier than normal with spotting for several days after which is very unusual for me.
Data exchange was not properly working in EHR office procedure did not include reconciliation of immunizations. (Only GRITS) causing extra dose to be given.
tested positive for COVID infection; tested positive for COVID infection; headache; felt sick/ did not feel well; This is a spontaneous report from a contactable consumer (patient's mother) from a Pfizer-sponsored program. A 16-year-old male patient received his first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not provided), via an unspecified route of administration on 16Mar2021 at single dose for COVID-19 immunisation. Medical history included being exposed to a person with COVID. The patient's concomitant medications were not reported. On 17Mar2021, the day after vaccination, the patient experienced headache and did not feel well, he felt sick. He was exposed to a person with COVID and later on, tested positive for COVID infection on 30Mar2021. The patient already recovered from COVID and wanted to know if he can get the second dose on their scheduled appointment on 15Apr2021. The outcome of the event "tested positive for COVID infection" was recovered on an unspecified date in 2021 and unknown for all other events. The events were reported as non-serious.   Information on lot/ batch number has been requested.
Patient received trumenba vaccination on 09/12/2019 and said soon after vaccination she developed a headache and low grade fever.  ER on Monday 9/16 with a headache with a pain 10/10 unrelieved with acetaminophen, ibuprofen as well as a family members oxycodone. In the ED  medication received was  diphenhydrAMINE (BENADRYL) tablet 25 mg,metoclopramide (REGLAN) tablet 10 mg , naproxen (NAPROSYN) tablet 500 mg and butalbital-acetaminophen-caffeine (FIORICET,ESGIC) 50-325-40 mg per tablet 1 tablet. Discharge home with rx for naproxen and to follow up with PCP. Fever has resolved she came back to the office on 09/18/2019 and said she still has a consistent headache.
Redness, swelling, warmth at injection site and entire upper arm. Fever 101 with hallucinations. Was seen at Urgent Care on 10/9/10 - ? infection - put on KEFLEX.
Kidney stone; feel pretty bad; Felt like he had the flu for a day; This is a spontaneous report from a contactable consumer. This consumer (patient) reported for himself that a male patient of unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 06Apr2021 at single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Patient stated that he received the first dose of the Pfizer Covid-19 vaccine on 06Apr2021 and he was scheduled to receive the second dose this Friday (30Apr2021). Stated that the first dose made him feel pretty bad and he felt like he had the flu for a day. He would like to know for how long he may reschedule the second dose as he currently has a kidney stone and he would go into surgery if the kidney stone does not pass during the weekend. Outcome of the events was unknown.   Information on the lot/batch number has been requested.
chest congestion; increased shortness of breath; feet swelling; face flushed; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RESPIRATORY TRACT CONGESTION (chest congestion), DYSPNOEA (increased shortness of breath), PERIPHERAL SWELLING (feet swelling) and FLUSHING (face flushed) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     Concurrent medical conditions included COPD.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, the patient experienced RESPIRATORY TRACT CONGESTION (chest congestion), DYSPNOEA (increased shortness of breath), PERIPHERAL SWELLING (feet swelling) and FLUSHING (face flushed). The patient was treated with PREDNISONE at a dose of 1 dosage form. At the time of the report, RESPIRATORY TRACT CONGESTION (chest congestion), DYSPNOEA (increased shortness of breath), PERIPHERAL SWELLING (feet swelling) and FLUSHING (face flushed) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications provided. treatment information included recuse inhaler   Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: Non-significant follow-up received on 28-MAY-2021 Contains contact information was updated.; Sender's Comments: Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.
On the 5th day, 4/13 I noticed unusual thirst at night  after my martial arts practice but I felt fine other than that. On the 6th day, 4/14 I had severe heaviness on back of my neck, fatigue, the arm where got shot itchiness, swelling, warmness, pain, heaviness, limit movement  when I woke up, and lasted all day. On the 7th day,4/15 no neck heaviness, but fatigue,  and the same symptoms on the arm. On the 8th day, today I feel better, less swelling, less pain, no itchiness, more movement in arm.
STRUGGLING FROM VACCINE DAMAGE; This spontaneous report received from a consumer via a company representative concerned multiple patients.  No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced struggling from vaccine damage. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of struggling from vaccine damage was not reported. This report was non-serious.
Sore arm, 9/4 and 9/5 Fatigue, 9/5 Started bleeding vaginally on 9/11 at 6:15pm. I?ve been breastfeeding and have not ovulated or had a period for the last 7 months since giving birth.
received BOOSTRIX, subject to temperature excursion; This case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a patient who received DTPa (Reduced antigen) (Boostrix) for prophylaxis.   On 24th February 2022, the patient received Boostrix. On an unknown date, unknown after receiving Boostrix, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown.  Additional details were provided as follows: The age at vaccination was not reported.  The reporter did not had patient identifiers of the patient. The health care professional reported that a patient received Boostrix that was subject to temperature excursion, which led incorrect storage of drug. The reporter consented to follow-up. The case was linked with case US2022AMR040207 and US2022AMR040208, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR040207:Same reporter US-GLAXOSMITHKLINE-US2022AMR040208:Same reporter
PATIENT C/O THICK TONGUE AND NUMBNESS 5 MINUTES AFTER VACCINATED WITH MODERNA AND WAS MONITORED FOR EXTRA 30 MINUTES.  PATIENT THEN C/O FEELING SHAKY BECAUSE OF NOT EATING LUNCH AND PATIENT WAS GIVEN PEANUT BUTTER CRACKERS.  PATIENT STATED SHE FELT BETTER AND WAS RELEASED FROM VACCINE POD.
Client is wheelchair bound and nonverbal client who was accompanied by her caregiver (whom remained at her side at the vaccination station). Client pulled shoulder away while vaccinating nurse was withdrawing the needle from client's shoulder. The vaccinating nurse confirmed that more than 50% of the 0.25 ml COVID-19 Moderna booster dose was administered into the client's right deltoid (only a drop leaked out). Vaccine Operations Lead  RN was notified and it was recommended that per CDC guidelines client would not need to be re-vaccinated because more than 50% of COVID-19 Moderna booster dose was administered into the client's shoulder. Client completed her 30 minute observation and was seen leaving facility with caregiver.
Starting two days after vaccine, area around location became hot, swollen, red, and painful. It rapidly spread down the arm, chest, and face. Hives appeared on hands and lip. The rash has moments where it flares up, especially in the evening. Skin is sensitive and feels burned. So far have tried Benadryl, Xyzal, Zyrtec, lotions and many other antihistamines to control it. Doctor gave a course of Prednisone to see if it would clear. It has not.
Bad Childhood memories ? Anxiety ? Mood swings - angry ? Racing ? Sensitive to pain ? knee,lung,ankle, & ringing in the ears  ? Severe Headache ? feels very heavy ? No sleep
Patient received the incorrect dose of 0.5mL versus the correct dose of 0.25mL no adverse event.
Ipsilateral axillary lymphadenopathy starting the day following the injection. Visible swelling and significant tenderness. Uncomfortable enough to require Motrin around the clock for 3 days. Resolved completed by day 5 after the injection.
Approximately 3 weeks and 2 days following the first Pfizer vaccine, I lost my sense of taste for 3 days. Approximately 2 hours after receiving the 2nd dose of Pfizer, I?ve had a metallic taste in my mouth and dull sense of taste, which is currently present now.
Patient was given .5ml of moderna instead of .25ml Patient complained of local reaction at the injection site.
Patient received HPV and flu vaccine at nurse clinic visit.  10 seconds later, felt face swell and become red, with subjective feeling of numbness and swelling of roof of mouth and throat.  No respiratory distress at the time.  Seen by physician, who noted mild periorbital edema and stable vitals but otherwise normal exam, and administered Benadryl.  Symptoms resolved.  Patient discharged home.  About 3.5 hours after vaccination, patient developed tightness in throat, shortness of breath and redness and swelling to with his eyes.  Went to ER, where physician noted mild bilateral conjunctival injection with some mild swelling around both eyes, and tachypnea.  Otherwise stable vitals.  Administered epi-pen 0.3 mg, Benadryl, Solumedrol, famotidine, NS bolus, observed for several hours.  Had complete resolution of symptoms.   Discharged with Orapred for 5 days, Benadryl as needed.
Severe headache dizzy neausea abdominal pain large rash horrible pain injection sight loss of left arm hand use
This case was reported by a healthcare professional via a sales representative and described the occurrence of swelling injection site in a subject of unspecified age and gender who was vaccinated with KINRIX (GlaxoSmithKline). On an unspecified date, the subject received unspecified dose of KINRIX (unknown route, injection site and batch number). 1 day after vaccination with KINRIX, the subject experienced swelling and redness at the injection site. At the time of reporting the outcome of the events was unspecified.
After receiving the second dose I had breakthrough menstruation five days later.  I am continuing to have breakthrough menstruation with cramping every two weeks or less.  September 16 I became extremely fatigued with a slight headache and nausea. Went in for a Covid test that came back negative.  I continue to feel lethargic daily.
This spontaneous report was received from a consumer refers to her son, 21 years old male patient. On unknown date, the patient was vaccinated with GARDASIL (lot number, dose and route not provided) as HPV vaccination. No other co-suspects were reported. No concomitant medications were reported. On an unknown date, the patient experienced headaches and swollen glands. No treatment information was reported. Blood work was done three weeks ago (results not provided). The patient sought medical attention. The outcome of headache and swollen glands was reported as not recovered. The relatedness for headache and swollen glands was unknown for GARDASIL. Additional information is not expected.
Information has been received from a pharmacist, referring to a female patient of unknown age. The patients' medical history, concurrent conditions and concomitant therapies were not reported. In January 2017, the patient were vaccinated with a dose of ZOSTAVAX (strength, dose, anatomical location, administration route, lot number and expiration date were not reported) for immunization. On unspecified date in January 2017 after vaccination, the patient experienced a rash around injection site and also developed 5 or 6 bumps around injection site. The reporting pharmacist recommended using hydrocortisone (manufacturer unknown) cream for the rash and when she followed up with the patient, the patient reported that rash was resolved with the treatment in January 2017. It was reported that the patient did not seek medical attention. The patient returned to the pharmacy approximately one month later (in February 2017) and reported that her symptoms had completely resolved. The causality between the vaccination with ZOSTAVAX and the events was unknown. No product quality complaint (PQC) was involved. This is one of two reports received from the same source. Additional information has been requested. Sender's Comments: US-009507513-1702USA000245.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 54-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 24Jan2021 at 11:00 as dose 1, single (Lot number: EL9263), in left arm, on 14Feb2021 at 13:00 as dose 2, single (Lot number: EN6201), in left arm, on 16Aug2021 at 15:00 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm and on 31Mar2022 at 15:30 as dose 4 (booster), single (Lot number: FC3181) at the age of 54 years, in left arm for covid-19 immunisation; BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 08Sep2022 at 13:30 as dose 5 (booster), single (Lot number: GH9694), in left arm for covid-19 immunisation. The patient's relevant medical history included: "High blood pressure" (unspecified if ongoing); "cholesterol" (unspecified if ongoing); "Known allergies: Shellfish" (unspecified if ongoing), notes: known allergies: Fish and shellfish; "Known allergies: Fish" (unspecified if ongoing), notes: known allergies: Fish and shellfish. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive, notes: covid-19 Treatment; (Sep2022) Positive, notes: Positive, test occurred on Day 12 following initial positive result; (17Sep2022) Negative, notes: Days 6-11 tested negative; (18Sep2022) Negative, notes: Days 6-11 tested negative; (19Sep2022) Negative, notes: Days 6-11 tested negative; (20Sep2022) Negative, notes: Days 6-11 tested negative; (21Sep2022) Negative, notes: Days 6-11 tested negative; (22Sep2022) Negative, notes: Days 6-11 tested negative. Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201182507 same reporter/patient, different drug/AE;US-PFIZER INC-202201183881 same reporter/patient, different dose/AE;
Approx 12 hrs after Td, L arm pain, weakness, chills - continued to following day.  Fine erythematous rash 2 days after injection.
Pt. complains of R arm pain post injection, pain located in deltoid muscle. No other symptoms, discomfort is consistent.
Fatigue and nausea starting in the evening and through the next day. Slept through most of the time and wasn't able to eat very much at the time.
approx 1 wk p/vax pt exp pressure in head & a cough;head pressure is unrelieved by propoxyphene;
This case was reported by a pharmacist via call center representative and described the occurrence of fever in a 49-year-old female patient who received SHINGRIX (batch number B5EK2, expiry date 28th April 2020) for prophylaxis. Previously administered products included SHINGRIX (On an unknown date received 1st dose). On 16th July 2018, the patient received the 2nd dose of SHINGRIX. On 16th July 2018, less than a day after receiving SHINGRIX, the patient experienced fever and vomiting. On an unknown date, the outcome of the fever and vomiting were not recovered/not resolved. It was unknown if the reporter considered the fever and vomiting to be related to SHINGRIX. Additional details were provided as follows: After receiving SHINGRIX, the patient experienced fever and vomiting. This has not yet resolved. This was a follow up to previously reported adverse event.
Shot area still hurts 1 month later (nerve stopped hurting) arm became so weak and painful that I could barely pull a shirt off over my head-that rotating motion pain/weakness began about 2 wks after shot and was at worst point 3-4 wks after. Still a problem.
headache; muscle soreness; This is a spontaneous report from non-contactable consumer (patient).  A 72-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on unknown date as single dose for Covid-19 immunisation at the age of 72-year-old . Medical history included headache. Concomitant medications included IBUPROFEN (IBUPROFEN ABECE). Historical vaccine included first dose of COVID-19 VACCINE on unknown date for covid-19 immunisation. On unknown date, the patient experienced muscle soreness in arm and headache. The outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Muscle soreness throughout entire left arm. Inability to raise left arm above shoulder for 48hours. Additional symptoms included head ache and body aches.